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Abstract  
Introduction: Reproductive outcome can be negatively affected in patients with congenital uterine 
anomalies (CUA), increasing the number of unsuccessful pregnancies and obstetric complications. 
Compared with the population with normally formed uterus, patients with CUA have higher abortion 
rate, higher fetal loss rate and decreased live birth rate. Hysteroscopic metroplasty (HM) is a 
standard, safe and minimally invasive method for the treatment of correctible types of congenital 
uterine anomalies. 
Aim: The aim of the study was to analyze the reproductive outcome in group of patients with 
infertility and recurrent pregnancy loss and present CUA, before and after hysteroscopic 
metroplasty.  
Material and Methods: We analyzed 67 patients to whom 78 interventions hysteroscopic 
metroplasty were performed at the University Clinic of Obstetrics and Gynecology in Skopje during 
a two year period, between 01.01.2010 and 31.12.2011. Their reproductive outcome was monitored 
during a two-year period and the same group served as a control group, taking into account their 
previous reproductive history. Statistical analysis was performed using Chi-square test and p < 0.05 
was considered to be statistically significant. 
Results: Most common CUA were types 5b and 6 represented by 88 %. In a follow up period of 
two years, 33 of the patients become pregnant. There was a statistically significant decrease of 
abortion rate from 92% to 21.2%, as well as an increase in the term delivery rate from 0% to 69.7%.  
Conclusion: Treatment with hysteroscopic metroplasty is significantly improving the reproductive 
outcome in patients with CUA and previous fetal loss.  
 
 
 
 
 
 
Introduction 
The influence of congenital uterine anomalies 
(CUA) on the reproductive outcome has been a 
research question for a long period of time, and 
studies found in the literature showed that the 
prevalence of the congenital uterine anomalies is 
around 1-10% in unselected population of women, 2-
8% in the group of infertile women, and 5-30% in 
women with a previous pregnancy loss [1-3]. 
Congenital anomalies of the female 
reproductive tract (Mullerian anomalies) represent a 
heterogeneous group of malformations of the genital 
tract, which can involve uterus, cervix, vagina and 
Fallopian tubes. Majority of reproductive tract 
anomalies can seriously influence the reproductive 
and obstetric health of women depending on the 
specificity of the anomaly. They increase the rate of 
abortions, preterm deliveries, and obstetric 
complications. Patients with uterine malformations 
have decreased reproductive potential and 
unfavorable reproductive outcome. Overall term 
pregnancy rate in patients with untreated uterine 
malformations is around 50%. Term delivery rate in 
pregnant patients with untreated septate and 
bicornuate uterus is ~40%, and in patients with 
arcuate uterus reproductive outcome is slightly better, 
with term delivery rate of ~65% [4]. Uterine septum is 
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the most present anomaly in patients with infertility, 
and possibly the most prone to a surgical correction 
[5].  
Congenital uterine anomalies consist of 
different groups of malformations of the Mullerian 
ducts, as a result of arrested embryological 
development, abnormal development or incomplete 
fusion of the paramesonephric ducts [6]. 
Etiology of CUA is not completely explained, 
majority of patients having normal karyotype, and 
some environmental, pharmacological and genetics 
factors might have some influence. Most probably its 
origin is polygenic or multifactorial [7]. 
Several classifications were made in order to 
optimize the diagnosis and treatment of those 
anomalies. The classification of the anomalies of the 
female reproductive tract depending on the degree of 
failure of normal development, in groups of similar 
clinical manifestations, treatment and prognosis for 
their reproductive outcome, had the most clinical 
practice and was adopted by the American Fertility 
Society (AFS) in 1988 [8], and is used worldwide.  
 
 
Figure 1: Schematic presentation of AFS classification. 
 
Optimal detection and diagnosis of the CUA is 
using combination of hysteroscopy, laparoscopy, 3D 
ultrasound, MRI and sonohysterosalpingography [9]. 
Hysteroscopy and laparoscopy is a standard, safe and 
minimally invasive method for precise detection, 
classification and treatment of uterine malformations 
[10-13]. 
Uterine cavity abnormality is considered to be 
one of the factors which influence the reproductive 
outcome of these patients. A surgical correction by 
hysteroscopic metroplasty (HM) has all the benefits of 
a good operative treatment: decreased intra- and 
postoperative morbidity, short-time intervention, less 
analgesic requirements, shorter hospital stay, shorter 
interval to conception and possibility for a vaginal 
delivery [13]. 
It provides anatomically normal uterine cavity, 
but does not certainly result in a favorable 
reproductive outcome since uterine vascularization is 
probably involved in the uterine function. The theory 
which is nowadays widely accepted, states that 
septum is consisted of fibroelastic tissue with 
inadequate vascularization and changed ratio 
between blood vessels of the endometrium and 
myometrium, presenting negative effects on 
decidualisation and placentation [14]. 
 
 
Figure 2: Hysteroscopic metroplasty in uterus septus. 
 
Majority of uterine malformations (> 55%) are 
presented with septate and arcuate uterus (type 5 and 
6 according to AFS classification), which can be 
effectively treated by means of operative 
hysteroscopy [14, 15]. Partial reconstruction of the 
uterine cavity by hysteroscopy is possible in some 
cases of partial bicornuate uterus (type 4b). 
Hysteroscopic metroplasty obtains normal uterine 
cavity, but also resolves normal uterine function, by 
providing normal reproductive outcome in these 
patients [16-18].  
 
Pregnancy loss 
Pregnancy loss (unsuccessful pregnancy) can 
be manifested in any period of pregnancy, starting 
even before implantation. Largest number (around 
2/3) of fetal loss after implantation cannot be clinically 
detected, only by means of HCG testing, so called 
biochemical pregnancy       [19-21].  Clinical rate of 
abortion diagnosis is 10-12%, which is well 
documented in a large number of retrospective and 
prospective studies. Fetal death occurs before the 
presence of clinical signs, and only 2-3 % of viable 
pregnancies are lost after 8 gestational week of 
pregnancy, usually in the following two months [22-
24]. 
Abortion causes can be of idiopathic, genetic, 
anatomical, autoimmune, endocrine and infective 
origine [25]. As a most present causes are considered 
chromosomal anomalies, infective agents, presence 
of uterine anomalies or other uterine pathology, 
antiphospholipid syndrome, uncontroled diabetes etc. 
According to the definitions  for infertility and 
recurrent pregnancy loss by the American Society for 
Reproductive Medicine, the following table was made 
(Table 1): 
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Even after one pregnancy loss , the risk for 
failure of the following pregnancy has been increased 
by 16-25%, and after second and third fetal pregnancy 
loss (unsuccessful pregnancy), the risk for following 
fetal loss has been increasing up to 40% [26,27]. 
Table 1: Terms Used to Describe Pregnancy Loss. 
Term Definition 
Chemical 
pregnancy loss 
Loss of a biochemically evident pregnancy 
Early pregnancy 
loss 
Abortion of the first trimester, loss of a histologically recognized 
pregnancy, or a loss based on ultrasonographic findings 
SAB* 
Pregnancy loss before 20 weeks' gestation, as based on last 
menstrual period 
Habitual or 
recurrent abortion 
2 or more consecutive SABs* 
Stillbirth 
Pregnancy loss after 20 weeks' gestation (Neonatal loss is the 
death of a liveborn fetus.) 
* The American Society for Reproductive Medicine (ASRM) Practice Committee Report 
redefined recurrent pregnancy loss in January, 2013 
 
That is why all patients with previous history 
of spontaneous abortion should include all necessary 
examinations searching for preventable causes for 
prevention of a future pregnancy loss. Investigation 
should be consisted of taking good medical history, 
thoroughly medical exam, patient counseling and 
adequate laboratory tests. Ultrasound scan should be 
mandatory in searching for the existence of uterine 
pathology, with special interest in detecting CUA.   
 
Table 2: Calculated risk for repetitive pregnancy loss for 
counselling patients with previous spontaneous abortions [26]. 
  Previous abortion Risk (%) 
Patients with 
previous live birth 
0 5–10 
  1 20–25 
  2 25 
  3 30 
  4 30 
Patients without 
previous live birth 
3 30–40 
 
The aim of this study was to analyze the 
reproductive outcome after hysteroscopic metroplasty 
in patients with infertility and recurrent pregnancy loss. 
 
Material and Method  
We analyzed 71  patients with  infertility and 
RPL to whom 84 interventions hysteroscopic 
metroplasty (HM) were performed at the University 
Clinic of Obstetrics and Gynecology in Skopje during 
a two year period, between 01.01.2010 and 
31.12.2011. Inclusion criteria for the study was 
diagnosis of uterine malformation of correctible types 
(4b, 5a, 5b and 6), according to the AFS classification, 
and exclusion criteria were existence of other 
intrauterine pathology (submucous myoma, polyp, 
etc.).  
Inclusion criteria were met by 67 patients, 
who underwent 78 interventions. Patients were 
divided in two groups: patients with recurrent 
pregnancy loss (RPL), and patients with infertility and 
previous pregnancy loss. Patients and their 
reproductive outcome were monitored during a two-
year period and the same group served as a control 
group for themselves, taking into account their 
previous reproductive history. Hysteroscopic 
metroplasty was done after previously signed 
informed consent by the patient. 
Intervention was done with endoscopic 
equipment (Olympus and Storz types), using a rigid 
hysteroscope of 5.5 mm and a resectoscope of 8 and 
9 mm, in general anesthesia and sterile conditions. 
Monopolar and bipolar current was used for the 
resection, with 50-70W strength and a special 
electrode (eza needle) of 4 mm length. A mixed 
solution Ispirol® (solution of 2.7% sorbitol and 0.54% 
manitol) or NaCl 0.9% solution, sterile and apyrogenic 
served as a distension media. 
Procedure starts with the patient placed in a 
lithotomic position, after previous disinfection of the 
operative field and vagina. Then cervix is pull forward 
with a tenaculum and dilatation is done using Hegar 
dilatators; the hysteroscope is placed transcervically 
into the uterine cavity. After visualization of both tubal 
ostia, resection of the septum starts in the midline 
between the anterior and posterior uterine wall and 
continues cranially towards the end point. End point is 
the moment when the following has been achieved: 
hysteroscope can move freely from one to the other 
ostium without obstruction, when both ostia are easily 
visualized from the upper part of the cavity or when 
more intensive bleeding starts from the place of the 
resection as a sign of proximity to the junction 
between the septum and the myometrium. In cases 
where major anomaly or uncertainty about achieving 
the end point of the resection was present, the patient 
is assigned for a control ultrasound and eventual re-
resection. 
The following variables associated with the 
reproductive outcome were monitored in our group of 
patients: pregnancy rate, abortion rate, preterm 
delivery rate and term delivery rate. 
Data were analyzed using the program SPSS 
for Windows, version 11.0. Statistical analysis was 
done using Chi-square test and p-value of 0.05 was 
considered to be statistically significant. 
 
Results 
The 67 patients were divided into two groups: 
the group with recurrent pregnancy loss consisted of 
24 patients (35.8%) and the group with infertility and 
previous fetal loss consisted of 43 patients (64.2%). 
Out of 78 performed HM, twenty-eight interventions 
Clinical Science 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
  106                                                                                                                                                                                                                     http://www.mjms.mk/ 
http://www.id-press.eu/mjms/ 
 
(35.9%) were done in the group of patients with RPL, 
and 50 (64.1%) in the infertility group. 
Comparing the number of diagnosed 
anomalies – the largest number of 45 (67.1%) 
hysteroscopic metroplasties were done in the group of 
patients with arcuate uterus (type 6), followed by the 
group of patients with partial septate uterus (type 5b) - 
14 cases (20.9%) and the group of patients with 
partial bicornuate uterus (type 4b) -6 cases (9%). The 
least present anomaly was complete septate uterus 
(type 5a) in 2 patients (3%). 
 
Figure 3: Graphic presentation of patients and hysteroscopic 
metroplasty by infertility groups. 
  
As represented in the most of the published 
literature, congenital uterine anomalies most present 
were types 5b and 6 - partial septate uterus and 
arcuate uterus, represented by 88 %. 
 
Table 3: Frequency of certain types of CUA by groups. 
Type of CUA RPL (%) Infertility (%) Total (%) 
4b 0 6 (14%) 6 (9%) 
5a 0 2 (4.6%) 2 (3%) 
5b 8 (33.3%) 6 (14%) 14 (20.9%) 
6 16 (66.7%) 29 (67.4%) 45 (67.1%) 
Total 24 (100%) 43 (100%) 67 (100%) 
 
According to the need for re-intervention 
(repeating the hysteroscopic metroplasty and 
resecting the residual septa) and types of CUA, the 
need to re-intervene was statistically significant in the 
groups with types 4b and 5a (3/8 – 37.5%), compared 
to the need for re-intervention of types 5b and 6 (9/59 
– 15.2%). This was expected since such types of 
uterine malformations have a bigger septum or 
indentation of the uterine fundus, requiring more 
careful resection and taking care not to perforate the 
uterus. 
Table 4: Types of CUA and need for re-intervention. 
Type of 
CUA 
Number of 
patients 
Re-
interventions 
Re-
reinterventions 
Total repeated 
HM by groups 
4b 6 1 (16.7%) 0  
3 (37.5%) 5a 2 1 (50.0%) 1 (50%) 
5b 14 3 (21.4%) 0  
9 (15.2%) 6 45 6 (13.3%) 0 
 
In the two-year period following hysteroscopic 
metroplasty, there were 33 patients who conceived. 
Analysis of the reproductive outcome in those patients 
(before and after hysteroscopic metroplasty) showed 
a statistically significant decrease (p < 0.05) of the 
abortion rate from 92% to 21.2%, as well as an 
increase in the term delivery rate from 0% to 69.7%. 
We noted increased preterm delivery rate (from 2% to 
9,1%), and no ectopic pregnancy after the 
hysteroscopic metroplasty (from 5% to 0%).  
 
Table 5: Reproductive outcome before and after metroplasty. 
Infertility 
and 
RPL 
group 
(67 
patients) 
No.of 
pregnancies 
(%) 
No.of 
abortions 
(%) 
Fetal 
loss 
after 
22gw 
(%) 
Ectopic 
pregnancy 
(%) 
Preterm 
delivery 
(%) 
Term 
delivery 
(%) 
Before 
HM 
100  
(100%) 
92  
(92%) 
1 
(1%) 
5  
(5%) 
2  
(2%) 
0 
(0%) 
After 
HM 
33  
(49.2%) 
7  
(21.2%) 
0 
(0%) 
0  
(0%) 
3  
(9.1%) 
23  
(69.7%) 
*S/NS / S S S S S 
*S-significant (p<0.05), NS-non-significant 
 
Discussion 
Hysteroscopic metroplasty is intervention 
designed for the treatment of patients with CUA that 
are hysteroscopicaly correctible, which are types 4b 
(partial bicornuate), 5a (complete septate), 5b (partial 
septate) and 6 (arcuate uterus). Systematic analysis 
of the obtained data showed a significant 
improvement in their reproductive outcome before and 
after hysteroscopic metroplasty.  
One of the first published trials made on this 
topic by Acien in 1993 [28] compared the reproductive 
outcome in 173 patients with untreated uterine 
malformation who had 383 pregnancies, and a second 
group of 28 patients with normal uterus and 47 
pregnancies. Abortion rate in patients with uterine 
malformations was 36%, and preterm delivery rate 
was 18%, which was significantly higher (p < 0.01) 
than the rate of abortions of 8% and preterm delivery 
rate of 6% in patients with normal uterus. Term 
delivery rate in patients with uterine malformations 
was 44% and live birth rate of 53%, which was lower 
and statistically significant (p < 0.001) from the group 
with normal uterus where term delivery rate was 85% 
and live birth rate of 89%.  
Analyzing the results from previous studies of 
Raga, Buttram and Heinonen [5, 29, 30] in a 
systematic review in 2001, Grimbizis found that in 102 
patients with untreated arcuate uterus and number of 
241 pregnancies, the abortion rate was 25.8% and 
prematurity rate was 7.5%. The rates for term delivery 
and live birth were 62.7% and 66%, respectively. In 
the group with untreated septate uterus he found an 
abortion rate of 44.3% and a preterm delivery rate of 
22.4%. After performing hysteroscopic metroplasty, a 
significant decrease in rates of abortions and preterm 
delivery was reported in treated patients. Abortion rate 
Tofoski & Georgievska. Reproductive Outcome after Hysteroscopic Metroplasty 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
OA Maced J Med Sci. 2014 Mar 15; 2(1):103-108.                                                                                                                                                                         107 
 
decreased to 16.4%, while preterm delivery rate 
decreased to 6.4%, while a significant rise of term 
deliveries and live birth was reported (76.3% and 
83.2%), in comparison with the rates before the HM 
that were lower (33% and 50.1%, respectively) [13]. 
In the previous study, done by Saygili in 2002 
[31], the reproductive outcome was analyzed in 361 
patients with septate uterus and hysteroscopic 
metroplasty who were followed during 18 months after 
the surgical intervention. The overall pregnancy rate 
was 49.8%, and during the 18 months follow-up 
period 58% of them were term deliveries, and 18.8% 
preterm deliveries. In the group with previous 
spontaneous abortions a huge decrease of abortion 
rate was noted, from 91.4% to 10.4%. In the primary 
infertility group pregnancy rate was up to 27.6%. 
Research done by Fedele et al. in 2006, who were 
monitoring the reproductive outcome before and after 
HM, observed a decrease in the abortion rate from 80-
90% to 20%, while the term delivery rate rose from 
5% to 80 % [32]. 
Study of Sendag in 2010 [33] who analyzed 
30 patients with different degrees of septate uterus, 
patients had a total 74 pregnancies before 
metroplasty. Of these, ten (14%) were carried to term, 
six (8%) ended in preterm delivery, and 58 (78%) 
ended in spontaneous abortion. At least one year 
following hysteroscopic metroplasty, a total of 20 
pregnancies occurred. Of these, 11 (55%) were 
carried to term, two (10%) ended in preterm delivery, 
seven (35%) ended in spontaneous abortion. 
In a recent study of Nouri in 2010 [34], 
reproductive outcome was evaluated after 
hysteroscopic metroplasty in 64 women with septate 
uterus and primary or infertility. Complete follow-up 
was available for 49/64 (76%) patients, with overall 
pregnancy rate after HM was 69% (34/49) and overall 
life birth rate was 49% (24/49).  
Roy et al. [35] in the published study in 2011 
have analyzed 170 cases with HM during the period of 
8.5 years where a significant decrease of 
unsuccessful pregnancies rate was noted, from 91.5% 
before metroplasty to 12.5% after metroplasty, and an 
increase in term delivery rate from 2.5% to 79.5%.  
The analysis of our material also showed a 
significant improvement in the reproductive outcome, 
which was in agreement with the published medical 
literature. The comparison of the results before and 
after HM revealed a significant decrease of abortion 
rate from 92 % to 21.1%, which was comparable with 
the analysis of Roy, Fedele and Saygili [31, 32, 35]. In 
the analyzed two-year period there was even a more 
significant improvement in the reproductive outcome 
resulting with term delivery rate that has increased 
from 0% to 69.7%, which was also significantly 
increased in all previously mentioned studies (from 
50-80%) [13, 31, 35]. This is a confirmation of the fact 
that obtaining normal uterine cavity in cases with 
congenital uterine malformations who have been 
hysteroscopically corrected, significantly influences 
the capacity of the uterus for successful continuation 
of the pregnancy to term delivery.  
In conclusion, congenital uterine anomalies, 
as a uterine factor for pregnancy loss, have been 
pointed in several published scientific papers 
concerning this topic. Even minor types of anomalies 
with small defect of the uterine cavity, have been 
shown as an important cause for pregnancy and 
recurrent pregnancy loss. After treatment with 
hysteroscopic metroplasty in patients where surgically 
correctible congenital uterine anomaly exists, a 
significant improvement of the reproductive outcome 
in these patients has been reported.  
We have analyzed the reproductive outcome 
before and after hysteroscopic metroplasty in our 
study group of patients diagnosed with infertility and 
recurrent pregnancy loss. A significant difference in 
the reproductive outcome has been noted, by 
decreased abortion rate and increased term delivery 
rates. The knowledge of the importance of detection 
and correction of congenital uterine anomalies will 
give new opportunities for a better reproductive 
outcome for this group of patients. 
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